Susan J Diem, Susan K Ewing, Katie L Stone, Sonia Ancoli-Israel, Susan Redline, Kristine E Ensrud
{"title":"Use of non-benzodiazepine sedative hypnotics and risk of falls in older men.","authors":"Susan J Diem, Susan K Ewing, Katie L Stone, Sonia Ancoli-Israel, Susan Redline, Kristine E Ensrud","doi":"10.4172/2167-7182.1000158","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To ascertain whether use of non-benzodiazepine sedative-hypnotics is associated with risk of falls and compare this to risk of falls associated with use of benzodiazepines.</p><p><strong>Methods: </strong>Among 4450 community-dwelling men, aged 71 years and older, enrolled in the population-based prospective cohort study, Osteoporotic Fractures in Men (MrOS), use of nonbenzodiazepine sedative-hypnotics and benzodiazepines was assessed by interview and verified from medication containers at the third annual visit of the MrOS study. Falls in the subsequent one-year period were ascertained by tri-annual questionnaires and a computerized dictionary used to categorize type of medication.</p><p><strong>Results: </strong>In age-adjusted models, non-benzodiazepine sedative hypnotic use was associated with an increased risk of any falls (one or more falls) (RR 1.44, 95% CI 1.15, 1.81) and recurrent falls (2 or more falls) (RR 1.51, 95% CI 1.07, 2.14). Use of benzodiazepines was associated with a similar increase in age-adjusted risk of falling. Depressive symptoms, inability to stand from a chair, and instrumental activities of daily living (IADL) impairment modestly attenuated these associations. The association between non-benzodiazepine sedative-hypnotic use and falls was most pronounced among men without a history of falls in the previous year: in a multivariable model controlling for multiple potential confounders, the RR of any falls was 1.74 (95% CI 1.13, 2.68) in this subgroup.</p><p><strong>Conclusions: </strong>Use of non-benzodiazepine sedative-hypnotics is associated with an increased risk of falls. Non-pharmacologic approaches to sleep disturbances may represent the safest approach to sleep difficulties in older adults.</p>","PeriodicalId":90221,"journal":{"name":"Journal of gerontology & geriatric research","volume":"3 3","pages":"158"},"PeriodicalIF":0.0000,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2167-7182.1000158","citationCount":"43","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gerontology & geriatric research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-7182.1000158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 43
Abstract
Background: To ascertain whether use of non-benzodiazepine sedative-hypnotics is associated with risk of falls and compare this to risk of falls associated with use of benzodiazepines.
Methods: Among 4450 community-dwelling men, aged 71 years and older, enrolled in the population-based prospective cohort study, Osteoporotic Fractures in Men (MrOS), use of nonbenzodiazepine sedative-hypnotics and benzodiazepines was assessed by interview and verified from medication containers at the third annual visit of the MrOS study. Falls in the subsequent one-year period were ascertained by tri-annual questionnaires and a computerized dictionary used to categorize type of medication.
Results: In age-adjusted models, non-benzodiazepine sedative hypnotic use was associated with an increased risk of any falls (one or more falls) (RR 1.44, 95% CI 1.15, 1.81) and recurrent falls (2 or more falls) (RR 1.51, 95% CI 1.07, 2.14). Use of benzodiazepines was associated with a similar increase in age-adjusted risk of falling. Depressive symptoms, inability to stand from a chair, and instrumental activities of daily living (IADL) impairment modestly attenuated these associations. The association between non-benzodiazepine sedative-hypnotic use and falls was most pronounced among men without a history of falls in the previous year: in a multivariable model controlling for multiple potential confounders, the RR of any falls was 1.74 (95% CI 1.13, 2.68) in this subgroup.
Conclusions: Use of non-benzodiazepine sedative-hypnotics is associated with an increased risk of falls. Non-pharmacologic approaches to sleep disturbances may represent the safest approach to sleep difficulties in older adults.
背景:确定使用非苯二氮卓类镇静催眠药是否与跌倒风险相关,并将其与使用苯二氮卓类药物的跌倒风险进行比较。方法:纳入以人群为基础的前瞻性队列研究“男性骨质疏松性骨折”(osteoporosis Fractures in men, MrOS)的4450名71岁及以上的社区男性,通过访谈评估非苯二氮卓类镇静催眠药和苯二氮卓类药物的使用情况,并在MrOS研究的第三次年度访问时从药物容器中进行验证。在随后的一年中,通过三年一次的问卷调查和用于分类药物类型的计算机字典来确定跌倒。结果:在年龄调整模型中,非苯二氮卓类镇静催眠药物的使用与任何跌倒(一次或多次跌倒)的风险增加(RR 1.44, 95% CI 1.15, 1.81)和复发跌倒(2次或以上跌倒)的风险增加(RR 1.51, 95% CI 1.07, 2.14)相关。苯二氮卓类药物的使用与年龄调整后跌倒风险的类似增加有关。抑郁症状、不能从椅子上站起来和日常生活工具性活动(IADL)障碍适度地减弱了这些关联。非苯二氮卓类镇静催眠药物的使用与跌倒之间的关联在前一年没有跌倒史的男性中最为明显:在控制多个潜在混杂因素的多变量模型中,该亚组中任何跌倒的RR为1.74 (95% CI 1.13, 2.68)。结论:使用非苯二氮卓类镇静催眠药物与跌倒风险增加有关。非药物方法治疗睡眠障碍可能是老年人睡眠困难最安全的方法。